SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
MA |
Click to view... | Registrant | About | Filings | Files | Relationships | Names | Topics | Web | ||||||||||||||||||||||||||||||
First | Latest Filing | Filing | Issuer / Subject | ||||||
---|---|---|---|---|---|---|---|---|---|
2/14/23 | 2/14/24 | SC 13G |
| 908 Devices Inc. | |||||
2/12/21 | 2/14/24 | SC 13G |
| Annexon, Inc. | |||||
2/14/24 | SC 13G |
| Celldex Therapeutics, Inc. | ||||||
2/12/16 | 2/14/24 | SC 13G |
| Collegium Pharmaceutical, Inc. | |||||
2/12/21 | 2/14/24 | SC 13G | Freeline Therapeutics Holdings plc [ formerly Freeline Therapeutics Holdings Ltd. ] | ||||||
2/14/24 | SC 13G |
| Inozyme Pharma, Inc. | ||||||
2/14/24 | SC 13G |
| Korro Bio, Inc. [ formerly Frequency Therapeutics, Inc. ] | ||||||
2/14/23 | 2/14/24 | SC 13G |
| Marinus Pharmaceuticals, Inc. | |||||
2/14/23 | 2/14/24 | SC 13G |
| Mirum Pharmaceuticals, Inc. | |||||
2/12/21 | 2/14/24 | SC 13G |
| Praxis Precision Medicines, Inc. | |||||
2/14/22 | 2/14/24 | SC 13G | VectivBio Holding AG | ||||||
11/13/23 | 2/14/24 | SC 13G |
| Xometry, Inc. | |||||
2/14/23 | 12/11/23 | SC 13G |
| Aura Biosciences, Inc. | |||||
12/11/23 | SC 13G |
| Lexeo Therapeutics, Inc. | ||||||
10/10/23 | 12/11/23 | SC 13G |
| Zentalis Pharmaceuticals, Inc. [ formerly Zentalis Pharmaceuticals, LLC ] | |||||
11/13/23 | SC 13G |
| VYNE Therapeutics Inc. [ formerly Menlo Therapeutics Inc. ] | ||||||
2/14/22 | 2/14/23 | SC 13G |
| Cogent Biosciences, Inc. [ formerly Unum Therapeutics Inc. ] | |||||
2/13/17 | 2/14/23 | SC 13G | ESSA Pharma Inc. | ||||||
2/10/22 | 2/14/23 | SC 13G |
| KnowBe4, Inc. | |||||
2/14/22 | 2/14/23 | SC 13G |
| Prometheus Biosciences, Inc. [ formerly Precision IBD, Inc. ] | |||||
→Please Sign In to List all of them. |
As Of | | Quarter (Ended) | Holdings Form 13F | Assets (Millions) | Reporting Manager | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/24 | 12/31/23 | 152 | $6,124,543 |
| Eventide Asset Management, LLC | |||||||||
11/14/23 | 9/30/23 | 155 | $3,429,701 |
| Eventide Asset Management, LLC | |||||||||
8/15/23 | 6/30/23 | 139 | $5,917 |
| Eventide Asset Management, LLC | |||||||||
5/15/23 | 3/31/23 | 149 | $5,450 |
| Eventide Asset Management, LLC | |||||||||
2/13/23 | 12/31/22 | 143 | $5,071 |
| Eventide Asset Management, LLC | |||||||||
11/14/22 | 9/30/22 | 138 | $5,083 |
| Eventide Asset Management, LLC | |||||||||
8/15/22 | 6/30/22 | 136 | $4,676 |
| Eventide Asset Management, LLC | |||||||||
5/16/22 | 3/31/22 | 136 | $6,382 |
| Eventide Asset Management, LLC |
Latest Filing | Registrant | Filings | |||||
---|---|---|---|---|---|---|---|
7/6/16 |
| Mutual Fund Series Trust | 4 |
Latest Filing | Group Member | Filings | |||||
---|---|---|---|---|---|---|---|
2/14/24 | • | Finny Kuruvilla, M.D. Ph. D. | 49 | ||||
2/14/24 | • | Robin C. John | 49 | ||||
7/15/19 | • | Eventide Gilead Fund | 2 | ||||
7/15/19 | • | Eventide Healthcare & Life Sciences Fund | 2 | ||||
7/15/19 |
| Finny Kuruvilla | 2 |
Latest Filing | Filing Agentª, Registrant or SEC — SEC # | Filings | |||||||
---|---|---|---|---|---|---|---|---|---|
Type | |||||||||
2/20/24 | 13F-HR/A |
| Blu Giant, LLC/FA — 1580642 | 127 | |||||
5/14/19 | 13F-HR | No Filing Agent: Self-filed — 1442891 | 24 | ||||||
8/13/08 | REGDEX | No Filing Agent: SEC-filed by SEC #7 — 9999999997 | 1 | ||||||
Total: | 152 | ||||||||
__________ ª Proprietary to SEC Info℠: The SEC does not publish the names of SEC Filing Agents. |